Saleh Shamse Basha: Severe Neonatal Anemia – When the Analyzer Tells a Story Before the Slide Does
Saleh Shamse Basha, Senior Hematology Technologist (Reference Lab, HQ) at PureLab, shared a post on LinkedIn:
“Case Discussion: Severe Neonatal Anemia – When the Analyzer Tells a Story Before the Slide Does
A newborn presented with Hb: 49 g/L, a critical value that immediately raises the question: hemolysis or hemorrhage?
Analyzer Findings (Sysmex XR-9000)
By looking at the WDF and WNR scattergrams, I felt something unusual – more striking than the critically low hemoglobin itself.
- TNC (Total Nucleated Cell): 78.74
- WBC: 11.26
- NRBC : 576/100 WBC
- Reticulocytes: 14%
The WNR channel is where the story begins.
It uses a lysing reagent that strips RBC and reticulocyte membranes but leaves NRBC nuclei intact, so both WBCs and NRBCs are counted together as the Total Nucleated Cell (TNC) count.
A related but separate issue appears on the WDF scattergram: immature NRBCs have larger nuclei that fall close to the WBC populations, sometimes overlapping the lymphocyte region and triggering a “WBC Abnormal Scattergram” flag.
When this happens, manual slide review and a true differential are essential in cases with marked NRBCs. The manual differential was very close to the analyzer count.
Blood Film
Marked anisopoikilocytosis with an elevated MCV, consistent with reticulocytosis.
Occasional target cells and schistocytes were also noted.
DAT: Negative, ruling out alloimmune hemolytic disease of the newborn.
Clinical History
Documented feto-maternal hemorrhage (FMH).
Interpretation
Putting it all together: severe anemia accompanied by reticulocytosis, marked NRBCs, a negative DAT, and a clinical history of feto-maternal hemorrhage is most consistent with acute or chronic blood loss anemia in the neonate secondary to massive FMH, rather than immune hemolysis.
The marrow response, evidenced by reticulocytosis together with marked NRBCs, is compensatory rather than causative.”

Stay updated with Hemostasis Today.
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy
-
Aug 2, 2026, 15:49Munira Borhany: Advancing Equity in Women’s Hematological Care
-
Aug 2, 2026, 14:54Every Second Counts: How CPR and AEDs Can Save a Life – American Heart Association
-
Aug 2, 2026, 14:38New French Guidelines for Acquired Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Aug 2, 2026, 14:36Sankesh Mehta: Restoring Venous Patency Through Mechanical Thrombectomy
-
Aug 2, 2026, 14:17Douglas Tavares: How Do We Get More People To Donate?
-
Aug 2, 2026, 14:06Omid Khalafi: Immature Reticulocyte Fraction – The Earliest Sign That Bone Marrow Is Responding